These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32231423)

  • 1. Landscape of BRIP1 molecular lesions in gastrointestinal cancers from published genomic studies.
    Voutsadakis IA
    World J Gastroenterol; 2020 Mar; 26(11):1197-1207. PubMed ID: 32231423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Mutational Analysis of the BRCA1-Associated DNA Helicase and Tumor-Suppressor FANCJ/BACH1/BRIP1.
    Calvo JA; Fritchman B; Hernandez D; Persky NS; Johannessen CM; Piccioni F; Kelch BA; Cantor SB
    Mol Cancer Res; 2021 Jun; 19(6):1015-1025. PubMed ID: 33619228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
    Cao AY; Huang J; Hu Z; Li WF; Ma ZL; Tang LL; Zhang B; Su FX; Zhou J; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Yuan WT; Shen ZZ; Huang W; Shao ZM
    Breast Cancer Res Treat; 2009 May; 115(1):51-5. PubMed ID: 18483852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of the breast cancer susceptibility gene BRIP1 /BACH1/FANCJ in high-risk non-BRCA1/BRCA2 breast cancer families.
    Guénard F; Labrie Y; Ouellette G; Joly Beauparlant C; Simard J; ; Durocher F
    J Hum Genet; 2008; 53(7):579. PubMed ID: 18414782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles.
    Seal S; Thompson D; Renwick A; Elliott A; Kelly P; Barfoot R; Chagtai T; Jayatilake H; Ahmed M; Spanova K; North B; McGuffog L; Evans DG; Eccles D; ; Easton DF; Stratton MR; Rahman N
    Nat Genet; 2006 Nov; 38(11):1239-41. PubMed ID: 17033622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel breast cancer-associated BRIP1 (FANCJ/BACH1) germ-line mutation impairs protein stability and function.
    De Nicolo A; Tancredi M; Lombardi G; Flemma CC; Barbuti S; Di Cristofano C; Sobhian B; Bevilacqua G; Drapkin R; Caligo MA
    Clin Cancer Res; 2008 Jul; 14(14):4672-80. PubMed ID: 18628483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rare
    Moyer CL; Ivanovich J; Gillespie JL; Doberstein R; Radke MR; Richardson ME; Kaufmann SH; Swisher EM; Goodfellow PJ
    Cancer Res; 2020 Feb; 80(4):857-867. PubMed ID: 31822495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRIP1, RAD51C, and RAD51D mutations are associated with high susceptibility to ovarian cancer: mutation prevalence and precise risk estimates based on a pooled analysis of ~30,000 cases.
    Suszynska M; Ratajska M; Kozlowski P
    J Ovarian Res; 2020 May; 13(1):50. PubMed ID: 32359370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FancJ (Brip1) loss-of-function allele results in spermatogonial cell depletion during embryogenesis and altered processing of crossover sites during meiotic prophase I in mice.
    Sun X; Brieño-Enríquez MA; Cornelius A; Modzelewski AJ; Maley TT; Campbell-Peterson KM; Holloway JK; Cohen PE
    Chromosoma; 2016 Jun; 125(2):237-52. PubMed ID: 26490168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicase-inactivating
    Kamal L; Pierce SB; Canavati C; Rayyan AA; Jaraysa T; Lobel O; Lolas S; Norquist BM; Rabie G; Zahdeh F; Levy-Lahad E; King MC; Kanaan MN
    Cold Spring Harb Mol Case Stud; 2020 Oct; 6(5):. PubMed ID: 33028645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancer.
    Weber-Lassalle N; Hauke J; Ramser J; Richters L; Groß E; Blümcke B; Gehrig A; Kahlert AK; Müller CR; Hackmann K; Honisch E; Weber-Lassalle K; Niederacher D; Borde J; Thiele H; Ernst C; Altmüller J; Neidhardt G; Nürnberg P; Klaschik K; Schroeder C; Platzer K; Volk AE; Wang-Gohrke S; Just W; Auber B; Kubisch C; Schmidt G; Horvath J; Wappenschmidt B; Engel C; Arnold N; Dworniczak B; Rhiem K; Meindl A; Schmutzler RK; Hahnen E
    Breast Cancer Res; 2018 Jan; 20(1):7. PubMed ID: 29368626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel role of BRCA1 interacting C-terminal helicase 1 (BRIP1) in breast tumour cell invasion.
    Rizeq B; Sif S; Nasrallah GK; Ouhtit A
    J Cell Mol Med; 2020 Oct; 24(19):11477-11488. PubMed ID: 32888398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary breast cancer and the BRCA1-associated FANCJ/BACH1/BRIP1.
    Cantor SB; Guillemette S
    Future Oncol; 2011 Feb; 7(2):253-61. PubMed ID: 21345144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity in FANCG, FANCF and BRIP1 from head and neck squamous cell carcinoma of the oral cavity.
    Türke C; Horn S; Petto C; Labudde D; Lauer G; Wittenburg G
    Int J Oncol; 2017 Jun; 50(6):2207-2220. PubMed ID: 28440438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the BRCA1-interacting protein Brip1/BACH1/FANCJ is driven by E2F and correlates with human breast cancer malignancy.
    Eelen G; Vanden Bempt I; Verlinden L; Drijkoningen M; Smeets A; Neven P; Christiaens MR; Marchal K; Bouillon R; Verstuyf A
    Oncogene; 2008 Jul; 27(30):4233-41. PubMed ID: 18345034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRCA1-mediated repression of mutagenic end-joining of DNA double-strand breaks requires complex formation with BACH1.
    Dohrn L; Salles D; Siehler SY; Kaufmann J; Wiesmüller L
    Biochem J; 2012 Feb; 441(3):919-26. PubMed ID: 22032289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unraveling the molecular effect of a rare missense mutation in BRIP1 associated with inherited breast cancer.
    Velázquez C; Esteban-Cardeñosa EM; Lastra E; Abella LE; de la Cruz V; Lobatón CD; Durán M; Infante M
    Mol Carcinog; 2019 Jan; 58(1):156-160. PubMed ID: 30230034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FANCJ helicase promotes DNA end resection by facilitating CtIP recruitment to DNA double-strand breaks.
    Nath S; Nagaraju G
    PLoS Genet; 2020 Apr; 16(4):e1008701. PubMed ID: 32251466
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Martín-Morales L; Garre P; Lorca V; Cazorla M; Llovet P; Bando I; García-Barberan V; González-Morales ML; Esteban-Jurado C; de la Hoya M; Castellví-Bel S; Caldés T
    Cancer Prev Res (Phila); 2021 Feb; 14(2):185-194. PubMed ID: 33115781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical importance of FANCD2, BRIP1, BRCA1, BRCA2 and FANCF expression in ovarian carcinomas.
    Moes-Sosnowska J; Rzepecka IK; Chodzynska J; Dansonka-Mieszkowska A; Szafron LM; Balabas A; Lotocka R; Sobiczewski P; Kupryjanczyk J
    Cancer Biol Ther; 2019; 20(6):843-854. PubMed ID: 30822218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.